Antivirals and Therapeutics for Flu disease

Antiviral drugs are prescription medicines that fight agaist the flu in your body. The two classes of antiviral drugs used against influenza are neuraminidase inhibitors (oseltamivir and zanamivir) and M2 protein inhibitors (adamantane derivatives). Food and Drug Administration (FDA) and European Agency for the Evaluation of Medicinal Products(EMEA), now a days force developers as well as manufacturers to improve their production and purification processes for viral vectors and vaccines.

Influenza is a highly infectious viral disease which can occur as a pandemic, epidemic, outbreak and in form of sporadic cases. influenza A viruses that infect humans, three major subtypes of hemagglutinins (H1, H2, and H3) and two subtypes of neuraminidases (N1 and N2). Type A has been associated with widespread epidemics and pandemics, while type B has been infrequently implicated in regional epidemics. Influenza type C infections cause only a mild respiratory illness. Humans are the primary reservoir. Animal reservoirs are suspected as sources of new human subtypes and may occur particularly when people and livestock (for example pigs and poultry) live closely together. Surveillance data is used to identify and monitor the arrival of influenza, its geographic spread, intensity of activity, characteristics of those infected, as well as severity and changing trends in order to guide prevention and control recommendations.

  • Antiviral drugs for influenza
  • Antiviral drug development and treatment strategies, including vaccination
  • Advances in viral detection and identification technologies
  • Antibiotic and antimicrobial resistance during flu infection
  • National and international surveillance and contingency strategies
  • Antibiotic and antimicrobial resistance during flu infection

Related Conference of Antivirals and Therapeutics for Flu disease

August 21-23, 2017

3rd Annual Congress on Infectious Diseases

San Francisco, California, USA
September 7-9, 2017

6thEuro-Global Conference on Infectious Diseases

Paris, France
September 13-14, 2017

6th Annual Bacteriology and Parasitology Meeting

Singapore
October 30-November 1, 2017

3rd Annual Congress on Rare Diseases and Orphan Drugs


(10 Plenary Forums - 1 Event)
San Antonio, Texas, USA
December 07-08, 2017

EuroSciCon Conference on STD-AIDS

Rome, Italy
March 1-2, 2018

5th International congress on Infectious Diseases

Berlin, Germany
June 18-19, 2018

EuroSciCon Conference on Bacteriology

Paris, France

Antivirals and Therapeutics for Flu disease Conference Speakers

Recommended Sessions

Related Journals

Are you interested in